Propylene Glycol

Propylene Glycol

SCHEMBL536044

CC(O)CO.CCCCCCOCCCCCC

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Propylene Glycol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.64
HTT P42858 2/20 0.61
MEN1 O00255 1/20 0.61
THRB P10828 1/20 0.61
KMT2A Q03164 1/20 0.61
MAPT P10636 1/20 0.61
SPHK1 Q9NYA1 1/20 0.52
TSHR P16473 1/20 0.50
CES2 O00748 2/20 0.47
TDP1 Q9NUW8 1/20 0.46
LPAR5 Q9H1C0 1/20 0.44
PLA2G2C Q5R387 1/20 0.44
HSD17B10 Q99714 1/20 0.43
LMNA P02545 1/20 0.43
CES1 P23141 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propylene Glycol SCHEMBL3181225 1.00 USP2 (0.64) USP2HTTMEN1THRBKMT2A
Propylene Glycol SCHEMBL2485076 1.00 USP2 (0.64) USP2HTTMEN1THRBKMT2A
Propylene Glycol SCHEMBL8641217 1.00 USP2 (0.64) USP2HTTMEN1THRBKMT2A
Propylene Glycol SCHEMBL5480105 1.00 USP2 (0.64) USP2HTTMEN1THRBKMT2A
Propylene Glycol SCHEMBL8646850 1.00 USP2 (0.64) USP2HTTMEN1THRBKMT2A
Propylene Glycol SCHEMBL669850 1.00 USP2 (0.64) USP2HTTMEN1THRBKMT2A
Propylene Glycol SCHEMBL2770664 1.00 USP2 (0.64) USP2HTTMEN1THRBKMT2A
Propylene Glycol SCHEMBL9070382 1.00 USP2 (0.64) USP2HTTMEN1THRBKMT2A
Propylene Glycol SCHEMBL8644290 1.00 USP2 (0.64) USP2HTTMEN1THRBKMT2A
Propylene Glycol SCHEMBL5469158 1.00 USP2 (0.64) USP2HTTMEN1THRBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115819196-A Method for treating propylene glycol ether rectifying still liquid 岳阳昌德新材料有限公司 2023-03-21 CN claimed
CN-112310361-B Silicon monoxide negative electrode material, electrode, preparation method and application thereof 宁波杉杉新材料科技有限公司 2022-02-08 CN claimed
US-11193079-B2 Glycol ether neo-esters, lubricating oil compositions containing same and processes for making same EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2021-12-07 US claimed
CN-113380998-A Silicon-carbon negative electrode material and preparation method and application thereof 夏秀明 2021-09-10 CN claimed
CN-109153919-B Enhanced steam extraction of bitumen from oil sands 陶氏环球技术有限责任公司 2021-07-16 CN claimed
CN-112310361-A Silicon monoxide negative electrode material, electrode, preparation method and application thereof 宁波杉杉新材料科技有限公司 2021-02-02 CN claimed
US-20200399552-A1 Glycol Ether Neo-Esters, Lubricating Oil Compositions Containing Same And Processes For Making Same EXXONMOBIL RES & ENG CO (US) 2020-12-24 US claimed
CN-111334381-A Wind driven generator cleaning agent and use method thereof 深圳市天正隆科技有限公司 2020-06-26 CN claimed
EP-2692807-B1 AQUEOUS COATING COMPOSITION DAINIPPON TORYO KK (JP) 2019-05-08 EP claimed
EP-2610271-B1 Preparation of phthalate free ZN PP catalysts BOREALIS AG (AT) 2019-03-20 EP claimed
EP-1720896-A1 PROCESS FOR REMOVING WATER FROM AQUEOUS SOLUTIONS OF PROTEINS The Dow Global Technologies Inc. (US) 2006-11-15 EP claimed
EP-1275686-B1 PROCESS FOR PRODUCING RECLAIMED EXPANDABLE POLYSTYRENE RESIN PARTICLE KAGOSHIMA PREFECTURE (JP) 2006-09-20 EP claimed
EP-1628320-A1 Barrier rib formation composition for manufacturing plasma display panel LG Electronics Inc. (KR) 2006-02-22 EP claimed
US-20060020050-A1 Barrier rib formation composition for manufacturing plasma display panel LG ELECTRONICS INC. 2006-01-26 US claimed
WO-2005092915-A1 PROCESS FOR REMOVING WATER FROM AQUEOUS SOLUTIONS OF PROTEINS DOW GLOBAL TECHNOLOGIES INC. (US) 2005-10-06 WO claimed
WO-2005087692-A2 PROCESS FOR RECOVERING ORGANIC COMPOUNDS FROM AQUEOUS STREAMS CONTAINING SAME DOW GLOBAL TECHNOLOGIES INC. (US) 2005-09-22 WO claimed
US-6649664-B2 Dissolving waste polystyrene foam in a volume reducing agent to form a compacted material; dipping in a suitable blowing agent to extract the agent; impregnating with the blowing agent to regenerate the expanded polystyrene; shaping KAGOSHIMAKEN (JP) 2003-11-18 US claimed
CN-1422300-A Process for producing reclaimed expandable polystyrene resin particles KAGOSHIMA PREFECTURE (JP) 2003-06-04 CN claimed
US-20030036576-A1 Process for producing reclaimed expandable polystyrene resin particle KAGOSHIMAKEN (JP) 2003-02-20 US claimed
EP-1275686-A1 PROCESS FOR PRODUCING RECLAIMED EXPANDABLE POLYSTYRENE RESIN PARTICLE Kagoshimaken (JP) 2003-01-15 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11193079-B2 Glycol ether neo-esters, lubricating oil compositions containing same and processes for making same ELOVL5, ELOVL1, NAPEPLD USP2 2570/4885HTT 1394/4885MEN1 2895/4885
US-20200399552-A1 Glycol Ether Neo-Esters, Lubricating Oil Compositions Containing Same And Processes For Making Same ELOVL5, ELOVL1, NAPEPLD USP2 2570/4885HTT 1394/4885MEN1 2895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.